GlassScriptPhysician profile
Asim Shabbir
NPI 1588686661
$523.72
in general payments reported to CMS, 2019-2025
8 companies · $32.18 in 2025
The $32.18 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.35 · 2020: $17.08 · 2021: $56.47 · 2022: $12.35 · 2023: $153 · 2024: $160 · 2025: $32.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $167.56 | 2023-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Asahi Intecc USA, INC. | $111.78 | 2024 | Peripheral Vascular |
| Portola Pharmaceuticals, LLC | $92.35 | 2019 | |
| Merck Sharp & Dohme LLC | $60.26 | 2020-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Cranial Technologies, INC | $31.17 | 2021-2024 | Doc Band |
| Sunovion Pharmaceuticals INC. | $28.42 | 2021 | |
| Glaxosmithkline, LLC. | $18.54 | 2025 | Bexsero, Rotarix |
| Hologic Sales and Service, LLC | $13.64 | 2025 | Aptima, Thinprep 2000 Processor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asim Shabbir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.